Novakand Pharma AB (publ) (LARK) — Net Asset Quality Index
Novakand Pharma AB (publ) (LARK) has a Net Asset Quality Index of 97.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr56.73 Million minus total liabilities of Skr1.24 Million yields net assets of Skr55.49 Million. A higher index indicates a stronger, lower-leverage balance sheet. For live market cap and overall valuation, see LARK stock market capitalisation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Novakand Pharma AB (publ) Net Asset Quality Index Over Time (2012–2025)
This chart shows how Novakand Pharma AB (publ)'s Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the index stands at 97.8%, representing net assets of Skr55.49 Million against total assets of Skr56.73 Million SEK. See LARK net assets for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Novakand Pharma AB (publ) (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Novakand Pharma AB (publ) from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Also explore Novakand Pharma AB (publ) annual equity growth to track the company's year-over-year net asset growth rate.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.8% | Skr55.49 Million | Skr56.73 Million | Skr1.24 Million | ▲ +3.5 pp |
| 2024 | 94.3% | Skr71.58 Million | Skr75.88 Million | Skr4.30 Million | ▼ -2.2 pp |
| 2023 | 96.6% | Skr116.46 Million | Skr120.61 Million | Skr4.16 Million | ▲ +0.4 pp |
| 2022 | 96.1% | Skr152.12 Million | Skr158.22 Million | Skr6.10 Million | ▲ +0.9 pp |
| 2021 | 95.2% | Skr158.28 Million | Skr166.22 Million | Skr7.94 Million | ▲ +5.3 pp |
| 2020 | 90.0% | Skr71.43 Million | Skr79.41 Million | Skr7.98 Million | ▲ +43.6 pp |
| 2019 | 46.3% | Skr20.30 Million | Skr43.82 Million | Skr23.51 Million | ▼ -11.9 pp |
| 2018 | 58.3% | Skr20.46 Million | Skr35.12 Million | Skr14.66 Million | ▼ -21.8 pp |
| 2017 | 80.0% | Skr6.51 Million | Skr8.14 Million | Skr1.63 Million | ▼ -3.4 pp |
| 2016 | 83.4% | Skr4.08 Million | Skr4.89 Million | Skr809.66K | ▼ -10.2 pp |
| 2015 | 93.7% | Skr10.27 Million | Skr10.96 Million | Skr691.73K | ▲ +3.0 pp |
| 2014 | 90.7% | Skr5.67 Million | Skr6.25 Million | Skr582.04K | ▼ -2.9 pp |
| 2013 | 93.6% | Skr598.60K | Skr639.58K | Skr40.98K | ▲ +43.5 pp |
| 2012 | 50.1% | Skr298.09K | Skr594.67K | Skr296.58K | — |